Astute and safe use of topical ocular corticosteroids in general practice : practical guidelines
dc.contributor.author | Janse van Rensburg, E. | |
dc.contributor.author | Meyer, D. | |
dc.date.accessioned | 2013-08-21T08:14:06Z | |
dc.date.available | 2013-08-21T08:14:06Z | |
dc.date.issued | 2013-04 | |
dc.description | The original publication is available at http://www.cmej.org.za/index.php/cmej | en_ZA |
dc.description.abstract | Corticosteroids are the most effective way to treat ocular inflammation. They relieve symptoms rapidly and often prevent permanent damage. These medications, however, must be used with caution, as use of steroid-containing topical drops can lead to serious side-effects. In situations where resources are limited it is often difficult to decide if steroids can be given safely. The purpose of this article is to briefly review the most important features of topical steroids and provide a practical and safe guideline for their use in general practice | en_ZA |
dc.description.version | Publishers' Version | en_ZA |
dc.format.extent | 3 p. | |
dc.identifier.citation | Janse van Rensburg, E. & Meyer, D. 2013. Astute and safe use of topical ocular corticosteroids in general practice : practical guidelines. Continuing Medical Education, 31(4):127-129. | en_ZA |
dc.identifier.issn | 2078-5143 (online) | |
dc.identifier.issn | 0256-2170 (print) | |
dc.identifier.uri | http://hdl.handle.net/10019.1/85346 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Health and Medical Publishing Group (HMPG) | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Adrenocortical hormones | en_ZA |
dc.title | Astute and safe use of topical ocular corticosteroids in general practice : practical guidelines | en_ZA |
dc.type | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jansevanrensburg_astute_2013.pdf
- Size:
- 150.58 KB
- Format:
- Adobe Portable Document Format
- Description:
- Publishers' Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.95 KB
- Format:
- Item-specific license agreed upon to submission
- Description: